Libeprosta

Lipidosterolic extract of Serenoa repens, the active ingredient in Libeprosta, is a herbal supplement presented as an oral preparation for use. It is intended to support men who experience benign prostatic hyperplasia and related urinary symptoms.

GNH USA supplies Libeprosta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Libeprosta is an herbal supplement that acts on the hormonal pathway involved in prostate enlargement and is used for conditions within the benign prostatic hyperplasia spectrum. - Benign prostatic hyperplasia: helps reduce urinary frequency, urgency and weak stream associated with an enlarged prostate. - Lower urinary tract symptoms: may improve nocturia and incomplete bladder emptying. - Prostate inflammation: can contribute to decreased inflammatory markers in the prostate tissue.

Adverse reactions to Libeprosta are generally mild but should be monitored.

Common Side Effects: - Gastrointestinal discomfort: mild stomach upset or nausea. - Headache: occasional tension‑type headache. - Dizziness: transient light‑headedness. - Skin rash: mild erythema or pruritus. - Fatigue: low‑grade tiredness.

Serious or Rare Side Effects: - Allergic reaction: swelling of face, lips or throat. - Hepatic dysfunction: elevated liver enzymes. - Severe rash: Stevens‑Johnson‑like presentation. - Hematuria: unexplained blood in urine. - Cardiovascular events: rare cases of chest pain or palpitations.

Before using Libeprosta, consider the following safety measures. - Medical history review: disclose any liver disease, hormonal disorders or prostate cancer. - Concomitant medications: inform the prescriber about anticoagulants, hormonal therapies or other herbal products. - Pregnancy and lactation: avoid use unless advised by a qualified health professional. - Age considerations: use caution in elderly patients with multiple comorbidities. - Storage: Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Libeprosta may interact with certain medicines; monitoring is advised.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - Hormonal therapies (e.g., finasteride): additive 5‑alpha‑reductase inhibition.

Moderate Interactions (Monitor Closely): - Antiplatelet agents: potential for enhanced antithrombotic effect. - CYP450 substrates: possible alteration of metabolism for drugs processed by CYP3A4. - Diuretics: may affect fluid balance and urinary output. - Herbal supplements: concurrent use with other prostate‑targeted botanicals could amplify effects.